Two studies [55, 58] showed that EGFR inhibitors AG1478 and erlortinib significantly upregulated apoptosis induced by inorganic AsBD arsenite and arsenic trioxide on various cancer cells, via a suppression of EGFR phosphorylation and a substantial inhibition of phosphorylated-AKT levels [55]. Here, EGFR is linked to cancer.